CLINICAL_TRIALS trial_result · 2025-06-05

Clinical Trial Update: Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy [Phase 3]

Phase 3 clinical trial results for nusinersen (BIIB058) in spinal muscular atrophy have been completed. The results were posted on 2025-06-05.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Phase 3 | Status: COMPLETED | Results posted: 2025-06-05